Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7200
0.00 (0.00%)
Sep 18, 2026, 3:59 PM HKT

HKG:3737 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6471,7372,2152,0501,8261,747
Revenue Growth
-5.21%-21.55%8.05%12.26%4.55%8.89%
Gross Profit
875.92940.251,2811,2151,0671,061
Operating Income
13.66-1.67125.14164.4103.5179.58
Net Income
17.6217.2995.21162.78106.3952.13
Earnings Per Share
0.020.020.110.190.130.06
EPS Growth
5.13%-81.82%-42.11%51.27%109.34%-64.10%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical Manufacturing
1,6651,8012,3332,1121,8481,877
Operation of Chain Pharmacies
512.11528.81590.49634.15696.03693.22
Elimination of Intersegment Sales
-529.97-592.07-708.24-696.22-717.95-823.96
Total
1,6471,7372,2152,0501,8261,747

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
185.38198.92199.69192.3419.36257.85
Total Debt
87.63130.01188.6174.86170.86175.74
Net Cash (Debt)
97.7568.9111.0917.45248.582.1
Net Cash Growth
41.86%521.45%-36.45%-92.98%202.67%-33.32%
Net Cash Per Share
0.120.080.010.020.290.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-179.7181.48101.5284.57178.38
Capital Expenditures
--35.22-140.76-169.18-88.41-185.85
Free Cash Flow
-144.4740.72-67.68196.17-7.47
Free Cash Flow Growth
-254.76%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.18%54.12%57.85%59.25%58.45%60.77%
Operating Margin
0.83%-0.10%5.65%8.02%5.67%4.56%
Pretax Margin
1.94%1.09%6.63%10.13%7.16%3.54%
Profit Margin
1.07%1.00%4.30%7.94%5.83%2.99%
FCF Margin
-8.31%1.84%-3.30%10.74%-0.43%

Dividends

Fiscal YearFY 2024FY 2023FY 2022
Period EndingDec '24 Dec '23 Dec '22
Dividend Per Share
0.0470.0820.053
Dividend Per Share Growth
-42.49%53.92%-
Dividend Yield
5.35%6.90%6.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
29.6625.148.446.847.8313.36
Forward PE
-10.3010.3010.3010.3010.30
P/FCF Ratio
-3.0119.73-4.25-
PS Ratio
0.330.250.360.540.460.40